Key Points
- CEO Jason Murray sold 35,975 PACS Group shares at an average price of $43.09, generating approximately $1.55 million. The transaction was conducted under a pre-arranged Rule 10b5-1 trading plan, and he retained roughly 54.4 million shares.
- Murray has made several additional stock sales recently, including more than $3.5 million in sales from October 1–7, according to the article.
- PACS Group recently beat quarterly earnings expectations, reporting $0.63 in EPS and $1.43 billion in revenue. Analysts maintain a “Moderate Buy” consensus rating with an average price target of $58.80, above the stock’s reported $43.02 price.
PACS Group, Inc. (NYSE:PACS - Get Free Report) CEO Jason Murray sold 717 shares of the firm's stock in a transaction on Wednesday, October 7th. The stock was sold at an average price of $42.48, for a total transaction of $30,458.16. Following the completion of the sale, the chief executive officer owned 54,435,249 shares of the company's stock, valued at $2,312,409,377.52. The trade was a 0.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Jason Hulse Murray also recently made the following trade(s):
- On Tuesday, October 6th, Jason Murray sold 35,975 shares of PACS Group stock. The shares were sold at an average price of $43.09, for a total transaction of $1,550,162.75.
- On Monday, October 5th, Jason Murray sold 24,224 shares of PACS Group stock. The shares were sold at an average price of $42.66, for a total transaction of $1,033,395.84.
- On Friday, October 2nd, Jason Murray sold 26,052 shares of PACS Group stock. The stock was sold at an average price of $42.51, for a total transaction of $1,107,470.52.
- On Thursday, October 1st, Jason Murray sold 33,032 shares of PACS Group stock. The stock was sold at an average price of $41.13, for a total transaction of $1,358,606.16.
- On Monday, September 14th, Jason Murray sold 317 shares of PACS Group stock. The shares were sold at an average price of $45.03, for a total value of $14,274.51.
- On Friday, September 11th, Jason Murray sold 10,529 shares of PACS Group stock. The shares were sold at an average price of $45.23, for a total value of $476,226.67.
- On Thursday, September 10th, Jason Murray sold 8,771 shares of PACS Group stock. The shares were sold at an average price of $45.16, for a total value of $396,098.36.
- On Wednesday, September 9th, Jason Murray sold 4,758 shares of PACS Group stock. The stock was sold at an average price of $43.33, for a total value of $206,164.14.
- On Tuesday, September 8th, Jason Murray sold 24,057 shares of PACS Group stock. The stock was sold at an average price of $43.49, for a total value of $1,046,238.93.
- On Friday, September 4th, Jason Murray sold 23,072 shares of PACS Group stock. The stock was sold at an average price of $42.69, for a total value of $984,943.68.
PACS Group Trading Up 0.5%
Shares of PACS Group stock opened at $43.02 on Thursday. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.91 and a current ratio of 0.91. PACS Group, Inc. has a 52 week low of $10.31 and a 52 week high of $49.49. The stock has a 50 day moving average price of $43.74 and a two-hundred day moving average price of $39.87. The stock has a market capitalization of $6.81 billion, a PE ratio of 25.01, a price-to-earnings-growth ratio of 1.34 and a beta of -0.08.
PACS Group (NYSE:PACS - Get Free Report) last released its quarterly earnings data on Tuesday, August 4th. The company reported $0.63 EPS for the quarter, beating the consensus estimate of $0.54 by $0.09. PACS Group had a return on equity of 29.55% and a net margin of 4.85%.The firm had revenue of $1.43 billion during the quarter, compared to the consensus estimate of $1.41 billion. As a group, equities analysts anticipate that PACS Group, Inc. will post 2.13 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
A number of analysts have commented on PACS shares. Weiss Ratings lowered shares of PACS Group from a "hold (c+)" rating to a "hold (c)" rating in a research note on Wednesday, August 5th. Truist Financial set a $62.00 price objective on shares of PACS Group in a research note on Wednesday, September 2nd. Oppenheimer lifted their price objective on shares of PACS Group from $48.00 to $57.00 and gave the company an "outperform" rating in a report on Monday, August 10th. Wall Street Zen downgraded shares of PACS Group from a "strong-buy" rating to a "buy" rating in a research report on Saturday, August 8th. Finally, JPMorgan Chase & Co. boosted their target price on shares of PACS Group from $47.00 to $58.00 and gave the stock an "overweight" rating in a research report on Friday, September 4th. Five investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $58.80.
Get Our Latest Analysis on PACS
Institutional Inflows and Outflows
Large investors have recently modified their holdings of the stock. Tidal Investments LLC bought a new stake in PACS Group during the second quarter worth $252,000. Engineers Gate Manager LP purchased a new stake in PACS Group in the 2nd quarter valued at $1,132,000. Integrated Wealth Concepts LLC bought a new position in PACS Group during the 2nd quarter valued at $75,000. Squarepoint Ops LLC lifted its stake in PACS Group by 94.7% during the 2nd quarter. Squarepoint Ops LLC now owns 59,523 shares of the company's stock valued at $2,538,000 after acquiring an additional 28,945 shares in the last quarter. Finally, Nykredit A S bought a new position in PACS Group during the 2nd quarter valued at $95,000.
PACS Group Company Profile
(
Get Free Report)
PACS Group, Inc is a healthcare services company that operates skilled nursing and other post-acute care facilities in the United States. Its facilities provide services for patients who require medical care, rehabilitation, recovery support, or assistance with daily activities following hospitalization or other acute health events.
The company's services generally include skilled nursing, physical and occupational therapy, speech therapy, long-term care, short-term rehabilitation, and other specialized post-acute programs.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
